FDA’s Woodcock Prioritizes Trial Networks As Drug Development Solution
This article was originally published in The Pink Sheet Daily
Executive Summary
Culture change, not congressional action is needed advance this step toward faster drug development, FDA’s drug leader tells Energy & Commerce Committee.